The commercialization of genome-editing technologies

  title={The commercialization of genome-editing technologies},
  author={Katelyn N. Brinegar and Ali K Yetisen and Sun Choi and Emily Vallillo and Guillermo U. Ruiz-Esparza and A. M. Prabhakar and A. Khademhosseini and S. Yun},
  journal={Critical Reviews in Biotechnology},
  pages={924 - 932}
  • Katelyn N. Brinegar, Ali K Yetisen, +5 authors S. Yun
  • Published 2017
  • Engineering, Medicine
  • Critical Reviews in Biotechnology
  • The emergence of new gene-editing technologies is profoundly transforming human therapeutics, agriculture, and industrial biotechnology. [...] Key Result These academic institutions, and their subsequent companies, are competing to generate comprehensive intellectual property portfolios to rapidly commercialize CRISPR products. Our analysis shows that the emergence of CRISPR has resulted in a fivefold increase in genome-editing bioenterprise investment over the last year. This entrepreneurial movement has…Expand Abstract
    27 Citations

    Topics from this paper

    Genome editing with the CRISPR‐Cas system: an art, ethics and global regulatory perspective
    • 3
    CRISPR-Cas systems: ushering in the new genome editing era
    • 12
    • Highly Influenced
    Modern Trends in Plant Genome Editing: An Inclusive Review of the CRISPR/Cas9 Toolbox
    • 23
    • PDF
    CRISPR Ethics: Moral Considerations for Applications of a Powerful Tool.
    • 33
    • PDF


    Expanding the genetic editing tool kit: ZFNs, TALENs, and CRISPR-Cas9.
    • 207
    • PDF
    The Impact of CRISPR/Cas9-Based Genomic Engineering on Biomedical Research and Medicine.
    • 10
    The Regulatory Status of Genome‐edited Crops
    • 156
    • Highly Influential
    • PDF
    How the US CRISPR patent probe will play out
    • 6
    • PDF
    CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes
    • 726
    • PDF
    Gene-edited CRISPR mushroom escapes US regulation
    • 236
    • PDF
    The new frontier of genome engineering with CRISPR-Cas9
    • 2,994
    • PDF
    CRISPR: Pursuit of profit poisons collaboration
    • 17
    • PDF
    Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells
    • 3,030
    • PDF
    Proceedings of the International Summit on Human Gene Editing: a global discussion—Washington, D.C., December 1–3, 2015
    • A. LaBarbera
    • Sociology, Medicine
    • Journal of Assisted Reproduction and Genetics
    • 2016
    • 16